JOHN TARBOX: Open Payments
NPI 1609359652 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,543 in 118 payments from 20 companies in 2025. Trend: 2023 $3,072 · 2024 $1,942 · 2025 $2,543
Food & beverage: $2,543
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $522 |
| ABBVIE INC. | 25 | $367 |
| AstraZeneca Pharmaceuticals LP | 7 | $279 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $191 |
| Lilly USA, LLC | 9 | $187 |
| Exact Sciences Corporation | 5 | $184 |
| Neurocrine BioSciences, Inc. | 4 | $181 |
| GlaxoSmithKline, LLC. | 11 | $172 |
| Verona Pharma, Inc. | 4 | $91 |
| Abbott Laboratories | 4 | $75 |
Products named: Ozempic, VRAYLAR, CAPLYTA, BREZTRI, INGREZZA, Wegovy, The Cologuard Plus Collection Kit, QULIPTA.
Industry payments across NY — which companies pay providers there.
